These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
596 related items for PubMed ID: 18405005
1. [Discovery of the splicing of peptides by the proteasome and study of preclinical models of anticancer immunotherapy]. Van den Eynde B. Bull Mem Acad R Med Belg; 2007; 162(5-6):352-6. PubMed ID: 18405005 [Abstract] [Full Text] [Related]
4. Overview of tumor cell-based vaccines. Copier J, Dalgleish A. Int Rev Immunol; 2006; 25(5-6):297-319. PubMed ID: 17169778 [Abstract] [Full Text] [Related]
5. New frontiers in cell-based immunotherapy of cancer. D'Elios MM, Del Prete G, Amedei A. Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938 [Abstract] [Full Text] [Related]
7. [General principles and first clinical trials of therapeutic vaccines against cancer]. Baurain JF, Van der Bruggen P, Van den Eynde BJ, Coulie PG, Van Baren N. Bull Cancer; 2008 Mar; 95(3):327-35. PubMed ID: 18390413 [Abstract] [Full Text] [Related]
9. Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity. Speiser DE, Romero P. Semin Immunol; 2010 Jun; 22(3):144-54. PubMed ID: 20413326 [Abstract] [Full Text] [Related]
12. Getting to the surface: a link between tumor antigen discovery and natural presentation of peptide-MHC complexes. Clark CE, Vonderheide RH. Clin Cancer Res; 2005 Aug 01; 11(15):5333-6. PubMed ID: 16061844 [No Abstract] [Full Text] [Related]
19. The cyclins: a family of widely expressed tumor antigens? von Bergwelt-Baildon MS, Kondo E, Klein-González N, Wendtner CM. Expert Rev Vaccines; 2011 Mar 01; 10(3):389-95. PubMed ID: 21434806 [Abstract] [Full Text] [Related]